Good news in Moderna’s quest for a Covid-19 vaccine is not translating to good fortune for the three billionaires behind the Massachusetts-based biotech company. Moderna’s vaccine wasby a Food and Drug Administration panel on Thursday, and will likely be approved for emergency use by the FDA later today — making it the second FDA-approved vaccine for the virus that has caused a global pandemic. That should lead to billions in revenues in 2021. Yet Moderna shares have been falling.
The decline in Moderna’s share price has shaved a collective $1.7 billion off of the net worths of Moderna CEO
Awwww poor BILLIONAIRES
18/12/2020 | VIGÍLIA GLOBAL - OS PROFETAS ANTIGOS DO SENHOR | PowerfulGlobalVigil
18/12/2020 | VIGÍLIA GLOBAL - OS PROFETAS ANTIGOS DO SENHOR | PowerfulGlobalVigil
thanks for this news
18/12/2020 | VIGÍLIA GLOBAL - OS PROFETAS ANTIGOS DO SENHOR | PowerfulGlobalVigil